Expertise in
36
conditions

Min S. Zhou

State Key Laboratory Of Bioreactor Engineering, 
Shanghai, CN 
Expertise in
36
conditions
State Key Laboratory Of Bioreactor Engineering, 
Shanghai, CN 
OverviewLocationsClinical Research

Overview

Min Zhou practices in Shanghai, China. Zhou is highly rated in 36 conditions, according to our data. Their top areas of expertise are Hypogonadism Primary Partial Alopecia, Thoracic Aortic Aneurysm, Abdominal Aortic Aneurysm (AAA), Aneurysm Repair, and Stent Placement.

Their clinical research consists of co-authoring 1437 peer reviewed articles and participating in 2 clinical trials. MediFind looks at clinical research from the past 15 years.

Locations

State Key Laboratory Of Bioreactor Engineering, Shanghai, 200237, China
Other Locations
No. 238, Jiefang Road, Wuhan, 430060, China
No. 1095 Jiefang Avenue, Wuhan, 430030, China
93 Ji Chuan Road, Taizhou, 225300, China
Guangzhou International Bio Island, Guangzhou, China
13 Hangkong Rd, Wuhan, 430030, China
No. 100, Daxue East Road, Nanning, 530004, China
321 Zhongshan Road, Nanjing, 210008, China
18 Daoshan Road, Fuzhou, 350001, China
Union Hospital, Wuhan, 430022, China
No. 200 Xiaolingwei Street, Nanjing, 210094, China
Yiheyuan Street. 5, Beijing, 100871, China
Jiefang West Road 61, Changsha, 410002, China
143 North Road, Qilihe, 730050, China
180 Fenglin Road, Shanghai, 200032, China
No.1095 Jie Fang Avenue, Wuhan, 430030, China
238 Jiefang Road, Wuhan, 430060, China
No. 197, Rui Jin Er Road, Shanghai, 200025, China
51 Fucheng Road, Beijing, 100048, China
No. 169, Donghu Rd, Wuhan, China
Middle Yanchang Road 399, Shanghai, 200072, China
No. 87 Xiangya Road, Changsha, 410008, China
321 Hankou Road, Nanjing, China

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

A Prospective, Single-arm, Open-label, Phase 2 Study to Evaluate Efficacy and Safety of R-GemOx Regimen as First-line Treatment in Elderly Patients With Diffuse Large B-cell Lymphoma (DLBCL).
A Prospective, Single-arm, Open-label, Phase 2 Study to Evaluate Efficacy and Safety of R-GemOx Regimen as First-line Treatment in Elderly Patients With Diffuse Large B-cell Lymphoma (DLBCL).
Enrollment Status: Unknown
Publish Date: February 15, 2019
Intervention Type: Drug
Study Drug: R-GemOx
Study Phase: Phase 2
A Prospective, Single-arm, Open-label, Phase 2 Study to Evaluate Efficacy and Safety of DA-EPOCH Regimen for Non-Hodgkin's Lymphoma With Hemophagocytic Lymphohistiocytosis
A Prospective, Single-arm, Open-label, Phase 2 Study to Evaluate Efficacy and Safety of DA-EPOCH Regimen for Non-Hodgkin's Lymphoma With Hemophagocytic Lymphohistiocytosis
Enrollment Status: Unknown
Publish Date: February 15, 2019
Intervention Type: Drug
Study Drug: DA-EPOCH
Study Phase: Phase 2
View 1 Less Clinical Trial

1437 Total Publications

Applications and Challenges of Exhaled Volatile Organic Compounds in Critically Ill Patients.
Applications and Challenges of Exhaled Volatile Organic Compounds in Critically Ill Patients.
Journal: Journal of breath research
Published: December 11, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Zhou's expertise for a condition
ConditionClose
    View All 31 Advanced Conditions
    View All 203 Experienced Conditions
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile